Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial - Cannon, C P; Cariou, B; Blom, D (Europ Heart J, 2015)
et al.